Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Return on Sales (2020 - 2025)

Historic Return on Sales for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 1.36%.

  • Strata Critical Medical's Return on Sales rose 12600.0% to 1.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.11% for FY2024, which is 1400.0% up from last year.
  • Strata Critical Medical's Return on Sales amounted to 1.36% in Q3 2025, which was up 12600.0% from 0.05% recorded in Q2 2025.
  • Strata Critical Medical's Return on Sales' 5-year high stood at 1.36% during Q3 2025, with a 5-year trough of 0.71% in Q4 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.13% (2024), whereas its average is 0.11%.
  • Per our database at Business Quant, Strata Critical Medical's Return on Sales crashed by -6000bps in 2021 and then soared by 12600bps in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Return on Sales stood at 0.03% in 2021, then tumbled by -1389bps to 0.4% in 2022, then plummeted by -77bps to 0.71% in 2023, then skyrocketed by 81bps to 0.13% in 2024, then surged by 1113bps to 1.36% in 2025.
  • Its last three reported values are 1.36% in Q3 2025, 0.05% for Q2 2025, and 0.06% during Q1 2025.